HS
CINC

HighVista Strategies’s CinCor Pharma, Inc. Common Stock CINC Stock Holding History

HighVista Strategies’s Portfolio CINC Stock Details CINC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-32,602
Closed -$401K – 140
2022
Q4 		$401K Buy
+32,602
New +$777K 0.24% 81

HighVista Strategies's CINC Position: Q1 2023 in Review

HighVista Strategies sold out of CinCor Pharma, Inc. Common Stock (CINC) in Q1 2023, closing a stake of 32,602 shares — an estimated $401K sold.

HighVista Strategies first reported a position in CINC in Q4 2022 and held it in 1 quarter. The position peaked at $401K in Q4 2022. 0 funds tracked by Wall St. Rank hold CINC as of Q1 2023.

  • HighVista Strategies reported no remaining CinCor Pharma, Inc. Common Stock position as of Q1 2023 after selling out during the quarter.
  • HighVista Strategies sold 32,602 CinCor Pharma, Inc. Common Stock shares in Q1 2023, an estimated $401K.
  • HighVista Strategies first reported a position in CinCor Pharma, Inc. Common Stock in Q4 2022 and held it in 1 quarter.
  • HighVista Strategies's CinCor Pharma, Inc. Common Stock position peaked at $401K in Q4 2022.
  • 0 funds tracked by Wall St. Rank held CinCor Pharma, Inc. Common Stock as of Q1 2023.

Based on HighVista Strategies's 13F filing for Q1 2023, filed 15 May 2023.